Emily S. Finn is assistant professor of psychological and brain sciences at Dartmouth College, where she directs the Functional Imaging and Naturalistic Neuroscience (FINN) Lab. Finn has pioneered techniques such as functional connectome fingerprinting and connectome-based predictive modeling for predicting individual behaviors from functional brain connectivity. Her current work is focused on how within- and between-individual variability in brain activity relates to appraisal of ambiguous information under naturalistic conditions such as watching movies or listening to stories.
Emily S. Finn
Assistant professor of psychological and brain sciences
Dartmouth College
From this contributor
To improve big data, we need small-scale human imaging studies
By insisting that every brain-behavior association study include hundreds or even thousands of participants, we risk stifling innovation. Smaller studies are essential to test new scanning paradigms.
To improve big data, we need small-scale human imaging studies
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.